Nexium (Esomeprazole Magnesium Trihydrate)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome and related acid‑related disorders.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium, a proton pump inhibitor, acts on the gastric acid secretion pathway to manage several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by lowering stomach acidity. - Erosive esophagitis: promotes healing of inflamed esophageal tissue through acid suppression. - Zollinger‑Ellison syndrome: controls excessive gastric acid production caused by gastrin‑secreting tumors. - NSAID‑induced gastric ulcer: reduces ulcer risk by limiting acid exposure. - Helicobacter pylori eradication (as part of combination therapy): enhances antibiotic effectiveness by creating a less acidic environment.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after initiation. - Diarrhoea: loose stools that may resolve with continued therapy. - Nausea: feeling of queasiness, usually transient.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, and breathing difficulty. - Low magnesium levels (hypomagnesemia): muscle cramps, weakness, or cardiac arrhythmia.

Before starting Nexium, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections. - Evaluate need for long‑term therapy: reassess benefits versus risks periodically. - Avoid abrupt discontinuation without medical advice: may cause rebound acid hypersecretion. - Review concomitant medications: potential for altered absorption or efficacy. - Store at room temperature: keep in the original pack, protect from moisture.

Nexium may interact with several medicines; monitoring is advised. Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption; avoid co‑administration. - Clopidogrel: decreased antiplatelet effect; consider alternative therapy. Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Digoxin: altered serum levels; check therapeutic range. - Methotrexate: increased toxicity risk; monitor renal function and drug levels.